---
figid: PMC7287658__molecules-25-02454-g006
figtitle: Model depicting the anti-tumor effect of the combined treatment with BEZ235
  and regorafenib in HCC cells
organisms:
- Homo sapiens
- Mus musculus
- Canis lupus familiaris
- Angelica sinensis
organisms_ner:
- Homo sapiens
- Mus musculus
- Drosophila melanogaster
pmcid: PMC7287658
filename: molecules-25-02454-g006.jpg
figlink: pmc/articles/PMC7287658/figure/molecules-25-02454-f006/
number: F6
caption: Model depicting the anti-tumor effect of the combined treatment with BEZ235
  and regorafenib in HCC cells. The combined treatment suppressed HCC cell migration
  and invasion through inhibition of the Akt/mTOR signaling pathway.
papertitle: The Synergistic Anti-Cancer Effects of NVP-BEZ235 and Regorafenib in Hepatocellular
  Carcinoma.
reftext: Cheng-Chan Yu, et al. Molecules. 2020 May;25(10):2454.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9462578
figid_alias: PMC7287658__F6
figtype: Figure
redirect_from: /figures/PMC7287658__F6
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7287658__molecules-25-02454-g006.html
  '@type': Dataset
  description: Model depicting the anti-tumor effect of the combined treatment with
    BEZ235 and regorafenib in HCC cells. The combined treatment suppressed HCC cell
    migration and invasion through inhibition of the Akt/mTOR signaling pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - RORC
  - EIF4EBP1
  - SNAI2
  - MMP2
  - ITK
  - SLC22A3
  - MMP9
  - HCC
  - HYCC1
  - Akt1
  - Mtor
  - tor
  - Rorc
  - Eif4ebp1
  - Snai2
  - Mmp2
  - Itk
  - Slc22a3
  - Mmp9
  - ot
  - Akt
  - Tor
  - Egfr
  - Thor
  - slug
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - BEZ235
  - Regorafenib
---
